Filing search / Ownership / VBI Vaccines Inc / Page 4

8-K

jjrod 4pq9mk

28 Feb 23

Regulation FD Disclosure

1:01pm

8-K

5h9 ci06sep

15 Feb 23

Regulation FD Disclosure

8:00am

8-K

hdzzwazs

30 Dec 22

Other Events

5:00pm

8-K

dl9cjnzcyraezx5hums

27 Dec 22

Regulation FD Disclosure

8:00am

8-K

lwgycpox5jl1mwodo1w6

8 Dec 22

VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults

8:00am

8-K

m6cwil0zlpvyvgrz

6 Dec 22

Entry into a Material Definitive Agreement

9:25am

8-K

nd7s2w9217qr3

22 Nov 22

VBI Vaccines Presents Additional Phase 1/2a Data from VBI-1901 in Recurrent GBM at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting

8:00am

8-K

qhpfprd2rq z9y7

10 Nov 22

VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update

8:00am

8-K

2j9s0r9

20 Oct 22

Entry into a Material Definitive Agreement

8:00am

8-K

2rh7jht6n 9adn3vctbe

12 Oct 22

Regulation FD Disclosure

8:00am

8-K

wa9h9

29 Sep 22

VBI Vaccines Announces Initiation of Phase 1 Study of Multivalent Coronavirus Vaccine Candidate, VBI-2901

8:00am

D

gw45 vzyfv

28 Sep 22

$0 in equity / options / securities to be acquired, 1 investor

4:11pm

8-K

kwybm8j

21 Sep 22

Regulation FD Disclosure

8:10am

8-K

lured7

15 Sep 22

VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures

5:01pm

8-K

tnuhavlip93rfnc s5ob

9 Sep 22

Departure of Directors or Certain Officers

5:00pm

8-K

waf 0d9g88

8 Sep 22

Regulation FD Disclosure

6:10am

EFFECT

7yg3 wumbdcjhg7tm

7 Sep 22

Notice of effectiveness

12:15am

UPLOAD

x8ca3hhgjenp70d

2 Sep 22

Letter from SEC

12:00am

CORRESP

eq3r4iqfjb1d

2 Sep 22

Correspondence with SEC

12:00am